Harbor Health Care ETF

MEDI
$33.49 -0.05 (-0.16%)
Dividend Yield 0.22%
Payout Frequency Yearly

Dividend History

Pay DateAmountEx-DateRecord Date
December 24, 2025$0.082025-12-192025-12-19
December 26, 2024$0.132024-12-202024-12-20
December 27, 2023$0.462023-12-212023-12-22

Dividends Summary

Company News

ETFs to Buy as Mounjaro Powers Eli Lilly's Q4 Earnings Beat
Zacks Investment Research • Sweta Killa • February 7, 2024

Eli Lilly and Company (LLY) posted robust fourth-quarter 2023 earnings, beating estimates on both the top and bottom lines driven by strong sales of its diabetes and weight-loss treatments.

UnitedHealth Beats on Q4 Earnings, Shares Slip: ETFs in Focus
Zacks Investment Research • Sweta Killa • January 15, 2024

The largest U.S. health insurer UnitedHealth Group (UNH) reported better-than-expected fourth-quarter 2023 results but medical costs rose more than expected for the first time in two years.

Eli Lilly Beats on Q3 Earnings: ETFs to Buy
Zacks Investment Research • Sweta Killa • November 3, 2023

Eli Lilly (LLY) posted robust third-quarter 2023 earnings results, beating estimates on both the top and bottom lines. Its Mounjaro anti-obesity drug continued its robust performance.

UnitedHealth Beats on Q3 Earnings, Raises View: ETFs to Gain
Zacks Investment Research • Sweta Killa • October 16, 2023

UnitedHealth (UNH) reported better-than-expected third-quarter 2023 results. Earnings and revenues breezed past the Zacks Consensus Estimate. The company also lifted the lower end of its full-year earnings guidance.

Eli Lilly Soars on Blockbuster Q2 Earnings: ETFs to Tap
Zacks Investment Research • Sweta Killa • August 9, 2023

Eli Lilly (LLY) experienced its most significant surge in stock prices in over two decades following the release of an impressive second-quarter 2023 earnings report and an optimistic outlook. ETFs having the largest exposure to the drug maker could be compelling picks to tap the strong growth.

Related Companies